Hemodynamics effects of adrecizumab in sepsis rat
Intensive Care Medicine Experimental(2015)
摘要
Sepsis and septic shock still represent major health issues, with persisting high morbidity and mortality rates in critically ill patients. Cardiac dysfunction[1] occurs frequently during severe sepsis.
Adrenomedullin (ADM) has been identified as a key mediator in vascular tone regulation[1]. A newly developed anti-ADM antibody Adrecizumab (ADZ) may improve hemodynamic dysfunction during resuscitated murine, cecal ligation and puncture (CLP)-induced septic shock[2].
更多查看译文
关键词
Septic Shock,Severe Sepsis,Mean Arterial Pressure,Hemodynamic Effect,Vascular Dysfunction
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要